
Lab-on-a-Chip and Microfluidics World Congress 2025
Date: Monday, November 17, 2025 - Wednesday, November 19, 2025
Location: VOCO Hotel - Laguna Hills, California
Confirmed Speakers

Brian Cunningham, Professor and Intel Alumni Endowed Chair, University of Illinois at Urbana-Champaign

Daniel Chiu, A. Bruce Montgomery Professor of Chemistry, University of Washington

Gregory Nordin, Professor, Brigham Young University

Jing Chen, Founder & CEO, Hicomp Microtech

Mais Jebrail, CTO of Microfluidics, INTEGRA Biosciences

Michelle Khine, Professor of Biomedical Engineering, University of California-Irvine

Stefano Begolo, President, ALine Inc. -- Conference Co-Chairperson

Wei Gao, Professor, California Institute of Technology

Chang-Jin "CJ" Kim, Distinguished Professor, University of California-Los Angeles

Ding Tang, Researcher in Bioengineering, University of Pennsylvania

H. John Crabtree, President and Founder, HJC Consulting Inc.

Juan G. Santiago, Charles Lee Powell Foundation Professor of Mechanical Engineering, Stanford University

Martyn Boutelle, Professor of Biomedical Sensors Engineering, Imperial College London

Noah Malmstadt, Professor, Mork Family Dept. of Chemical Engineering & Materials Science, University of Southern California

Steve Soper, Foundation Distinguished Professor, Director, Center of BioModular Multi-Scale System for Precision Medicine, The University of Kansas

Yang Lin, Assistant Professor, University of Rhode Island

Claudia Gärtner, CEO, microfluidic ChipShop GmbH

Dino Di Carlo, Armond and Elena Hairapetian Chair in Engineering and Medicine, Professor and Chair of Bioengineering, University of California Los Angeles -- Conference Co-Chairperson

Holger Schmidt, Narinder Kapany Professor of Electrical Engineering, University of California-Santa Cruz

Magdalena Urban, Researcher, University of Strathclyde

Maximilian Pitzek, Deputy Head of Project Management, STRATEC Consumables GmbH

Roman Voronov, Associate Professor, Otto H. York Department of Chemical and Materials Engineering, New Jersey Institute of Technology Newark College of Engineering

Victor Morel Cahoreau, Head of Sales, Eden Microfluidics
Lab-on-a-Chip & Microfluidics World Congress 2025
Welcome to the SelectBIO 18th Annual Lab-on-a-Chip & Microfluidics 2025 Conference to be held at the VOCO Hotel -- Laguna Hills, California.
Bringing together researchers and industry participants from both academia and industry, this established congress now in its 18th consecutive year, will discuss the latest innovations and developments in the Lab-on-a-Chip (LOAC) and Microfluidics fields -- The Emphasis of the 2025 Conference is "From Research to Commercialization." Presentations will explore the latest advances in the Lab-on-a-Chip & Microfluidics Fields. Focus at this conference will also be given to some of the many applications of Lab-on-a-Chip, from life science research, to taking diagnostics to the point-of-care/point-of-need and body-on-a-chip/organs-on-a-chip.
We focus on LOAC device production technologies, novel designs/technologies for manufacture, as well as the key application areas for LOAC from research to diagnostics as well as 3D-bioprinting and the convergence of microfluidics technologies with biofabrication and 3D-printing.
**Additionally, at this 2025 event, there will be session dedicated to Digital Microfluidics (DMF)**
There is an Extensive International Perspective at this Conference with Speakers, Poster Presenters, Sponsors, and Exhibitors from the US, Europe, and Asia/Pacific.
Running alongside the conference will be an exhibition covering the latest technological advances and associated products and services from leading solution providers within this field from around the world.
Registered delegates will have full access to the co-located and concurrent tracks and sessions to mix-and-match presentations and maximize networking:
Lab-on-a-Chip and Microfluidics: Techologies, Companies and Commercialization 2025
Innovations in Extracellular Vesicles Research 2025: Technologies, Tools, Demos & Applications
Biofabrication and Biomanufacturing 2025
Abstract Submission for Oral Presentations & Posters
You can present your research in an oral presentation or via a poster whilst attending the Conference. Submit an abstract for consideration on the Submissions page of this Conference Website.
Oral Presentation Abstract Submission Deadline: July 31, 2025
Poster Submission Deadline: October 31, 2025
Agenda Topics Covered at this Conference
3D-Printing and its Convergence with the Microfluidics/Lab-on-a-Chip Marketplace
3D-Printing, Biofabrication and Bioprinting using Microfluidics
Digital Microfluidics
Lab-on-a-Chip and Microfluidics for Point-of-Care Diagnostic Testing and Global Health Applications
Microfluidic/LOAC Device Manufacturing: Technologies and Companies Showcase
Microfluidics and Lab-on-a-Chip: Life Science Research Applications
Microfluidics Tools for Single Cell Analysis
New Entrants from Around the World Expand the Market Opportunities for Microfluidics and Lab-on-a-Chip
Rare Cell Capture & Circulating Biomarkers Studied Using Microfluidics
Sponsorship and Exhibition Opportunities
3 for 2 Offer on Delegate Registrations
SelectBIO are offering 3 Delegate Registrations for the price of 2 on all delegate passes. To take advantage of this offer, please contact us by email, phone or click the Contact Us button below. Looking for more than 3 Delegate Passes? Contact us for more information on our special rates for large groups.
Any questions or assistance during registration, please call us at: +1 (510) 857-4865 or e-mail us at: Contact SelectBIO
Gold Sponsors
Exhibitors
Lab-on-a-Chip and Microfluidics World Congress 2025
If you require any information about exhibiting or sponsoring at one of our events please contact Jeff Fan using the information below:
Jeff Fan
Exhibition Manager - SelectBIO Conferences
Why Exhibit/Sponsor at a SelectBIO Conference?
Specialists: SelectBIO doesn't organize conferences in shipping, accountancy, textiles etc. – just drug discovery and the life sciences. Many of our staff have bioscience qualifications and many years of experience. So, we speak your language and understand your needs.
Superior Customer Service: Our sales team will take care of you with specialist advice and customized packages. We don’t forget you after you sign on the bottom line either as our customer service dept. will alert you to all the things you need to think about up to and during the event itself.
Lab-on-a-Chip and Microfluidics World Congress 2025 Conference Venue
SelectBIO is delighted to host the 18th Annual Lab-on-a-Chip and Microfluidics World Conference 2025 at VOCO Laguna Hills: An IHG Hotel -- Laguna Hills, California.
VOCO Laguna Hills
25205 La Paz Road
Laguna Hills, California 92653, USA
This hotel in Southern California is easily accessible from Los Angeles and San Diego via Interstate-5 (I-5).
The nearest airport is: John Wayne Airport (SNA) - 13.7 miles from the hotel.
From Los Angeles International Airport (LAX) - the hotel is 52.9 miles.
The hotel is within a short drive of Disneyland and Legoland California, as well as Laguna Beach, Newport Beach, as well as shopping and dining at South Coast Plaza in Costa Mesa.
All conference sessions, exhibition as well as networking receptions will be held in the Conference Center at VOCO Laguna Hills.
SelectBIO has negotiated discounted hotel room pricing for conference attendees at VOCO Laguna Hills.
To make your Hotel Reservations Online: Click the Button Below to Open the Hotel Booking Website This will provide a SelectBIO discounted rate for booking hotel rooms.
Discounted Room Pricing per Night is US$139.00 + taxes and fees additional.




For any hotel reservation-related issues, or if you need any help with hotel bookings, please contact:
Jeff Fan
Events Manager, SelectBIO Conferences
E-mail: Jeff@selectbioconferences.com
SelectBIO has NOT authorized ANY third party company to assist in hotel bookings or reservations for the conference. Please do NOT do business with any third party companies. If in doubt, please contact Jeff Fan immediately to clarify.
Register to this conference and also enjoy the following co-located events at no extra charge.
Training Courses
3D-Printing of Microfluidics
17 November 2025 from 20:30 - 22:30
The Slate Room -- VOCO Hotel, Laguna Hills, California
3D printing has been gaining popularity as a method for rapidly producing microfluidic devices with complex channel structures routed in three dimensions.
This short course will cover:
Mechanisms of 3D printing techniques as applied to microfluidic fabrication,
The state of the art of commercially available solutions for microfluidic printing
Applications and limitations of 3D-printed microfluidic systems
How emerging and future technologies will improve the potential of 3D printing as a microfluidic fabrication tool

Noah Malmstadt, Professor of Chemical Engineering and Materials Science, University of Southern California
If you would like to submit a proposal for an oral or poster presentation at this meeting, please fill out the form below required for your submission.
Successful applicants will be provided with all necessary information.
Abstract Content:
-
Written in English
-
Written in the third person
-
Include title, name(s) and affiliation(s) of the authors
-
Between 100 - 200 words
-
Suitable for direct publication in the proceedings pack and on the website
-
Related to the subject of the conference
Agenda Topics
3D-Printing and its Convergence with the Microfluidics/Lab-on-a-Chip Marketplace
3D-Printing, Biofabrication and Bioprinting using Microfluidics
Digital Microfluidics
Lab-on-a-Chip and Microfluidics for Point-of-Care Diagnostic Testing and Global Health Applications
Microfluidic/LOAC Device Manufacturing: Technologies and Companies Showcase
Microfluidics and Lab-on-a-Chip: Life Science Research Applications
Microfluidics Tools for Single Cell Analysis
New Entrants from Around the World Expand the Market Opportunities for Microfluidics and Lab-on-a-Chip
Rare Cell Capture & Circulating Biomarkers Studied Using Microfluidics
Copyrights
The presenting author/person who submitted the abstract assumes full responsibility of the content of the abstract and we assume that all co-authors are aware of this content. Please note that your biography, summary and abstract may be used on this website and conference materials.
Brian Cunningham, Professor and Intel Alumni Endowed Chair, University of Illinois at Urbana-Champaign

Brian Cunningham Biographical Sketch
Professor Cunningham has been a faculty member in the department of Electrical and Computer Engineering and the department Bioengineering at the University of Illinois at Urbana-Champaign since 2004, following a 15-year career in Industry. Prof. Cunningham’s technical focus is the utilization of photonics for biosensing in applications that include life science research, diagnostics, environmental monitoring, and pharmaceutical screening. He has over 90 issued US patents and over 200 peer reviewed journal publications. He is a Fellow of NAI, IEEE, Optica, RSC, AAAS, and AIMBE. He serves as the Director of the Center for Genomic Diagnostics at the Woese Institute for Genomic Biology, and as a Program Leader for the Cancer Center at Illinois on the topic of Cancer Measurement Technology and Data Science. In 2023, his technical contributions were recognized by Optica by the Michael S. Feld Biophotonics Award.
Chang-Jin "CJ" Kim, Distinguished Professor, University of California-Los Angeles

Chang-Jin "CJ" Kim Biographical Sketch
CJ Kim is a Distinguished Professor and holds the Volgenau Endowed Chair in Engineering at UCLA. He received his B.S. from Seoul National University, M.S. from Iowa State University, and Ph.D. from the University of California, Berkeley. Directing Micro and Nano Manufacturing Lab at UCLA, he performs research in MEMS with a focus on utilizing surface tension. The recipient of the NSF CAREER Award, Ho-Am Prize in Engineering, and IEEE Bosch MEMS Award, and fellow of ASME, IEEE, and AIMBE, Professor Kim is serving on the editorial board of several journals and as co-Editor-in-Chief of Droplet.
Claudia Gärtner, CEO, microfluidic ChipShop GmbH

Claudia Gärtner's Biographical Sketch
Dr. Claudia Gärtner studied chemistry and biology and has earned her diploma and PhD in chemistry at the University of Düsseldorf in 1996. Between 1996 and 1999, she worked as an assistant to the Director at the Institute for Microtechnology in Mainz (IMM), where she coordinated large scale international projects (e.g. TMR-project MICROSYNC, LSF-project). In 1999 she was appointed Director of the Application Centre for Microtechnology in Jena, a daughter institution of the Fraunhofer Institute for Applied Optics and Precision Engineering. In 2002 she founded MFCS together with Dr. Holger Becker. Since April 2006 she is CEO of microfluidic ChipShop. She has been coordinator of numerous R&D projects on national and international level, including the FP 7 IP Multisense Chip. In 2017 she was decorated with the 3rd prize as Women Innovator competition by the European Commission. She is in the board of trustees of the German Museum in Munich and the advisory board of the Trade Fair in Erfurt, Thuringia, Germany. Lab-on-a-Chip system as bleed-to-read-systems including their manufacturing and commercialization are in her focus.
Daniel Chiu, A. Bruce Montgomery Professor of Chemistry, University of Washington

Daniel Chiu Biographical Sketch
Daniel T. Chiu is currently the A. Bruce Montgomery Professor Chemistry, Endowed Professor of Analytical Chemistry, and Professor of Bioengineering at the University of Washington. He is a member of the University of Washington’s Center for Nanotechnology, Neurobiology and Behavior Program, and the Cancer Consortium of the Fred Hutchinson Cancer Research Center. He has authored more than 180 publications and is the inventor on over 40 issued patents. Dr. Chiu obtained a B.A. in neurobiology and a B.S. in chemistry at the University of California, Berkeley in 1993, and a Ph.D. in chemistry from Stanford University in 1998.
Ding Tang, Researcher in Bioengineering, University of Pennsylvania

Ding Tang Biographical Sketch
Ding Tang is a PhD Candidate in Bioengineering at the University of Pennsylvania, where he conducts research in the lab of Professor David A. Issadore. His work focuses on developing ultrasensitive nucleic acid quantification platforms by integrating droplet microfluidics with CRISPR-based diagnostics, with the goal of advancing early infectious disease detection, point-of-care testing, and global health surveillance. Prior to joining Penn, Ding earned a Master of Translational Medicine from UC Berkeley–UC San Francisco and an MS in Biomedical Engineering from Columbia University. Outside the lab, he is a dedicated marathon runner and has completed over 70 races across the United States. He has served as a brand ambassador for several major running events, including the 2024 Philadelphia Marathon Weekend, the 2024 Philadelphia Distance Run, and the 2025 Philly 10K.
Dino Di Carlo, Armond and Elena Hairapetian Chair in Engineering and Medicine, Professor and Chair of Bioengineering, University of California Los Angeles

Dino Di Carlo Biographical Sketch
Dino Di Carlo received his B.S. in Bioengineering from the University of California, Berkeley in 2002 and received a Ph.D. in Bioengineering from the University of California, Berkeley and San Francisco in 2006. From 2006-2008 he conducted postdoctoral studies in the Center for Engineering in Medicine at Harvard Medical School. He has been on the faculty in the Department of Bioengineering at UCLA since 2008 and now as Professor of Bioengineering and Mechanical Engineering serves as the Chair of the Department and as the director of the Cancer Nanotechnology Program in the Jonsson Comprehensive Cancer Center. His research pioneered the use of inertial fluid dynamic effects for the control, separation, and analysis of cells in microfluidic devices. His recent work extends into numerous other fields of biomedicine and biotechnology including directed evolution, cell analysis for rapid diagnostics, new amplified molecular assays, next generation biomaterials, and phenotypic drug screening. He has also been a leader in technology entrepreneurship: He co-founded and currently serves on the board of directors of five companies that are commercializing UCLA intellectual property developed in his lab (CytoVale, Vortex Biosciences, Tempo Therapeutics, Forcyte Biotechnologies and Ferrologix). Among other honors he received the Presidential Early Career Award for Scientists and Engineers (PECASE) and was elected a Fellow of the American Institute for Medical and Biological Engineering in 2016, was elected a Fellow of the Royal Society of Chemistry (FRSC) in 2014, was awarded the National Science Foundation (NSF) Faculty Early Career Development award and the U.S. Office of Naval Research (ONR) Young Investigator Award, the Packard Fellowship and Defense Advanced Research Projects Agency (DARPA) Young Faculty Award, and received the National Institutes of Health (NIH) Director’s New Innovator Award and Coulter Translational Research Award.
Gregory Nordin, Professor, Brigham Young University

Gregory Nordin Biographical Sketch
Professor Greg Nordin joined the faculty of the Electrical & Computer Engineering Department at Brigham Young University in 2005. From 1992 to 2005 he was at The University of Alabama in Huntsville (UAH) where he was the founding director of the university's Nano and Micro Devices Center, which was created as an independent research center by the University of Alabama System Board of Trustees. While director of the center, he created a 7,600 sq. ft. cleanroom facility for nano and microfabricated devices to pursue research activities in photonics, MEMS, microfluidics, and sensors. Prof. Nordin has led numerous large research programs, and has been principal investigator on research grants from government and industry totaling $18M. He is the recipient of the National Science Foundation CAREER award (1996) for promising young faculty, and twice received the UAH Outstanding Researcher Award as well as the UAH Foundation Award for Research and Creative Achievement. Prof. Nordin's current research is focused on developing 3D printing for microfluidic devices and applications. In March 2018 Prof. Nordin gave a TED talk on his group's work, which is available at https://www.youtube.com/watch?v=T122fzOEVYE.
H. John Crabtree, President and Founder, HJC Consulting Inc.

John Crabtree Biographical Sketch
John Crabtree, Ph.D., P.Chem, PMP, has over 25 years of experience in product development and research relating to microfluidics and analytical chemistry-based technology. He got his B.Sc. in chemistry from the University of Toronto, his Ph.D. in analytical chemistry from the University of Alberta, and did his PDF with Andreas Manz at Imperial College. He spent a decade at Micralyne Inc. (now Teledyne MEMS, a glass/Si fabrication house) leading internal and client microfluidic development projects. He then was PM for a multidisciplinary team developing PCR diagnostics at the U. of A., after which he founded his consultancy, HJC Consulting Inc., in 2012.
HJC Consulting Inc. supports technology-based microfluidic product development (PD), investment due diligence investigations and acquisition on-boarding, IP review and landscaping, and corporate content creation. John has authored over 20 publications, given numerous conference presentations and chaired symposia and workshops focused on microfluidic technology and products. He is a Professional Chemist (P. Chem.) as well as a Project Management Professional (PMP), and sat/sits on the boards of several industry groups and professional regulatory organizations.
Holger Schmidt, Narinder Kapany Professor of Electrical Engineering, University of California-Santa Cruz

Holger Schmidt Biographical Sketch
Holger Schmidt received the Ph.D. degree in electrical and computer engineering from the University of California Santa Barbara and served as a Postdoctoral Fellow at M.I.T. He is currently the Narinder Kapany Chair of Optoelectronics and Distinguished Professor of Electrical and Computer Engineering at UC Santa Cruz. He directs the W.M. Keck Center for Nanoscale Optofluidics and has served as the Associate Dean for Research in the Baskin School of Engineering. His research interests cover a broad range in photonics and integrated optics, including optofluidic devices, nanopore sensors, nano-magneto-optics, spintronic devices, and ultrafast optics. He has authored more than 400 publications, several book chapters, and co-edited the CRC Handbook of Optofluidics. He is a Fellow of the National Academy of Inventors, the IEEE and the Optical Society of America. He received an NSF Career Award, a Keck Futures Nanotechnology Award, and the Engineering Achievement Award by the IEEE Photonics Society.
Jing Chen, Founder & CEO, Hicomp Microtech

Jing Chen Biographical Sketch
Dr. Jing Chen has amassed 28 years of expertise in Microfluidics, MEMS, and Manufacturing Engineering. He earned his PhD from Tsinghua University, furthered his research at the University of Michigan, and served as a tenured professor at Peking University for 16 years. In 2014, Dr. Chen founded HiComp, which specializes in microfluidic and lab-on-chip products for various industries. He has authored over 180 papers, 70 patents, and 6 books, making significant contributions to the field.
Juan G. Santiago, Charles Lee Powell Foundation Professor of Mechanical Engineering, Stanford University

Juan Santiago Biographical Sketch
Juan G. Santiago received his MS and PhD in Mechanical Engineering from the University of Illinois at Urbana-Champaign in 1995. He is the Charles Lee Powell Foundation Professor of Mechanical Engineering at Stanford University. His research includes the development of microsystems for on-chip biochemical analysis, biophysics studies of DNA and CRISPR, and flow electrode electrochemical systems. Applications of this include molecular diagnostics, DNA mapping, and the production of drinking water. He is a Fellow of the American Physical Society, a Fellow of the American Society of Mechanical Engineering, and a Fellow of the American Institute for Medical and Biological Engineering. He is a Fellow of the American Academy of Arts and Sciences (2022) and of the National Academic of Inventors (2022). He serves as the Founding Editor-in-Chief of the journal Flow. His work is cited more than 1500 times per year and has an h index of 94 (Google Scholar). He has authored and co-authored over 220 journal papers and 250 conference papers, and he is a named inventor in 60 issued patents (20 of which are currently licensed).
Magdalena Urban, Researcher, University of Strathclyde

Magdalena Urban Biographical Sketch
Magdalena Urban is a researcher at the University of Strathclyde, supervised by Dr. Andrew Reid. Her work focuses on acoustofluidic lab-on-a-chip systems for modeling the blood–brain barrier (BBB), to advance drug screening and neurovascular research. She holds an MSc in Experimental Nuclear Physics and a BSc in Medical Physics from the University of Lodz, Poland, as well as an HND in Industrial Biotechnology from Glasgow Clyde College. Her research explores the integration of acoustic actuation with microengineered platforms to develop a physiologically relevant in vitro BBB model, enabling advanced investigation into drug permeability and neurovascular interactions. Her interdisciplinary background spans the physical and life sciences, encompassing medical imaging, radiation dosimetry, cell and molecular biology, and chemical engineering principles relevant to lab-on-a-chip technology. Ms. Urban’s early research was focused on ionizing radiation detection and dose optimization in clinical fluoroscopy, as well as beta spectroscopy of neutron-activated scintillators. These projects reflect her strong foundation in experimental physics and quantitative analysis, which she now applies to the design and characterization of microfluidic systems. Her scientific interests lie at the convergence of microscale engineering, biomedical diagnostics, and translational neuroscience, with a particular emphasis on developing functional microphysiological models for neurological research.
Mais Jebrail, CTO of Microfluidics, INTEGRA Biosciences

Mais Jebrail Biographical Sketch
Mais Jebrail, PhD, is the CTO of Microfluidics at INTEGRA Biosciences and an expert in microfluidics with extensive experience in the biotech industry, ranging from chemistry to clinical applications. He completed his PhD at the University of Toronto and pursued postdoctoral research at Sandia National Labs. At INTEGRA Biosciences, he is driving innovation in microfluidic technologies for life sciences. With a strong background in technology development and commercialization, Dr. Jebrail has contributed to multiple patents and has published many peer-reviewed papers in the areas of microfluidic device design, diagnostic applications, and next-generation sequencing. He continues to push the boundaries of microfluidics in biotechnology.
Martyn Boutelle, Professor of Biomedical Sensors Engineering, Imperial College London

Martyn Boutelle Biographical Sketch
Martyn Boutelle is Professor of Biomedical Sensors Engineering in the Department of Bioengineering, Imperial College London, and Associate Provost for Estates Planning for Imperial College. His research group is multidisciplinary comprising bioengineers, scientists, and clinicians. He develops novel analytical science methods using microfluidics, electrochemical sensors / biosensors, and wireless electronics to make portable (sometimes wearable) monitoring devices for use as point of care devices – typically giving continuous real -time displays. He then uses these in a program of clinical science research focusing on the neonatal monitoring, acute traumatic brain injury, pesticide exposure monitoring. Martyn is past president of the International Society for Monitoring Molecules in Neuroscience, and a founder of the COSBID organization for studying acute human brain injury. He published > 200 papers, chapters and patents. He obtained a BSc and PhD in Chemistry from Imperial College and worked as an EP Abraham Research Fellow in the University of Oxford.
Maximilian Pitzek, Deputy Head of Project Management, STRATEC Consumables GmbH

Maximilian Pitzek Biographical Sketch
Maximilian Pitzek is the deputy head of the Project Department at Stratec Consumables, responsible for all early consumable development projects, i.e. microfluidic design and experimental design validation. Max has studied Physics at the Department of Medical Physics, at the University of Innsbruck, Austria, and has worked at Stratec for 14 years, and developed microfluidic chips in the field of single cell sequencing (e.g. BD Rhapsody System), single cell IVD (e.g. Cytovale IntelliSep System), digital PCR Platforms, and several others that are subject to confidentiality.
Michelle Khine, Professor of Biomedical Engineering, University of California-Irvine

Michelle Khine Biographical Sketch
Michelle Khine, Ph.D. is a Professor of Biomedical Engineering and Associate Dean of Undergraduate Education at UC Irvine. She is the founding Director of Faculty Innovation at the Samueli School of Engineering and founding Director of BioENGINE (BioEngineering Innovation and Entrepreneurship) at UC Irvine. Prior to joining UC Irvine, she was an Assistant & Founding Professor at UC Merced. Michelle received her BS and MS from UC Berkeley in Mechanical Engineering and her PhD in Bioengineering from UC Berkeley and UCSF. She is the Scientific Founder of 6 start-up companies. Michelle was the recipient of the TR35 Award and named one of Forbes ’10 Revolutionaries’ in 2009 and by Fast Company Magazine as one of the '100 Most Creative People in Business' in 2011. She was awarded the NIH New Innovator's Award, was named a finalist in the World Technology Awards for Materials, and was named by Marie‐Claire magazine as 'Women on Top: Top Scientist'. She was named Entrepreneurial Leader of the Year 2025 at UC Irvine. Michelle is a Fellow of AIMBE (American Institute of Medical and Biological Engineering) and a Fellow of the National Academy of Inventors.
Noah Malmstadt, Professor, Mork Family Dept. of Chemical Engineering & Materials Science, University of Southern California

Noah Malmstadt Biographical Sketch
Noah Malmstadt is Professor at the University of Southern California. He received a BS in Chemical Engineering from Caltech and a PhD in Bioengineering from the University of Washington. Following postdoctoral work at UCLA, he joined the Mork Family Department of Chemical Engineering and Materials Science at USC in 2007. Malmstadt is the recipient of a 2012 Office of Naval Research Young Investigator award. His research focuses on microfluidic strategies to facilitate material fabrication and biophysical analysis. He has pioneered the integration of ionic liquids as solvents in droplet microreactors and the application of microfluidic systems to synthesizing biomimetic cell membranes. Microfluidic analytical techniques he has developed include methods for measuring the permeability of cell membranes to druglike molecules and techniques for measuring ionic currents through membrane proteins.
Roman Voronov, Associate Professor, Otto H. York Department of Chemical and Materials Engineering, New Jersey Institute of Technology Newark College of Engineering

Roman Voronov Biographical Sketch
Roman S. Voronov is a tenured Associate Professor of Chemical and Material’s Engineering at the New Jersey Institute of Technology (NJIT), since September 2013. He also holds a joint appointment in Biomedical Engineering since 2020. Additionally, Prof. Voronov is the founder and president of an STTR-funded startup company AltVIVO, Inc. that specializes in producing advanced cell culturing equipment. His laboratory has two main research directions: computer-driven tissue engineering, and blood systems biology. Prof. Voronov’s work in these areas has been funded by NIH, NSF and private ventures. Prior to his appointment at NJIT, Prof. Voronov was an American Heart Association Postdoctoral Fellow in the Department of Chemical & Biomolecular Engineering at the University of Pennsylvania. Prior to that, Dr. Voronov held a brief post-doctoral appointment at the University of Oklahoma (OU) studying enhanced oil recovery from porous rock formations as a part of Advanced Energy Consortium. He received his PhD in 2010, MS in 2006, and BS (Summa Cum Laude with a Minor in Physics) in 2003 in Chemical Engineering from OU.
Stefano Begolo, President, ALine Inc.

Stefano Begolo Biographical Sketch
Dr. Stefano Begolo, PhD, PMP, EMBA, is the President of ALine Inc., where he leads the commercialization of microfluidic technologies through product development and pilot manufacturing. He holds a B.S. and M.S. in Materials Science and Engineering from the University of Padua (Italy) and earned his Ph.D. in Physics from Université Pierre et Marie Curie (Paris VI) in 2011. His doctoral research focused on droplet microfluidics for DNA and protein detection, as well as innovative technologies for microfluidic device fabrication. At the California Institute of Technology, Dr. Begolo played a key role in developing instrument-free platforms for point-of-care diagnostics, leveraging 3D printing and the patented SlipChip technology. He is the co-author of twelve peer-reviewed publications, five patents, and multiple patent applications.
Steve Soper, Foundation Distinguished Professor, Director, Center of BioModular Multi-scale System for Precision Medicine, The University of Kansas

Steve Soper Biographical Sketch
Professor Soper (since 2016) is a Foundation Distinguished Professor in Chemistry and Mechanical Engineering at the University of Kansas. At KUMC, Prof. Soper holds an adjunct appointment in the Cancer Biology Department and is a member of the KU Cancer Center. He also holds an appointment at Ulsan National Institute of Science and Technology in Ulsan, South Korea, where he is a World Class University Professor.
As a result of his efforts, Prof. Soper has secured extramural funding totaling >$125M, has published over 245 peer-reviewed manuscripts (h index = 70; >17,000 citations); 31 book chapters and 71 peer-reviewed conference proceeding papers, and is the author of 12 patents. He is also the founder of a startup company, BioFluidica, which is marketing devices for the isolation and enumeration of liquid biopsy markers. Soper recently founded a second company, Sunflower Genomics, which is seeking to market a new DNA/RNA single-molecule sequencing platform. His list of awards includes Ralph Adams Award in Bioanalytical Chemistry, Chemical Instrumentation by the American Chemical Society, the Benedetti-Pichler Award for Microchemistry, Fellow of the AAAS, Fellow of Applied Spectroscopy, Fellow of the Royal Society of Chemistry, R&D 100 Award, Distinguished Masters Award at LSU and Outstanding Scientist/Engineer in the state of Louisiana in 2001. Finally, Prof. Soper has granted 50 PhDs and 7 MS degrees to students under his mentorship. He currently heads a group of 15 researchers.
His major discoveries include: (1) Technology for the detection of liquid biopsy markers that can manage a variety of diseases using a simple blood test (test has been demonstrated in multiple myeloma, pediatric acute lymphoblastic leukemia, acute myeloid leukemia, pancreatic, breast, colorectal, prostate, and ovarian cancers); (2) new hardware and assay for the point-of-care diagnosis of acute ischemic stroke; (3) single-molecule DNA and RNA sequencing nanotechnology; and (4) currently working on a home-test for COVID-19 infections (handheld instrument and the associated assay.
Victor Morel Cahoreau, Head of Sales, Eden Microfluidics

Victor Morel Cahoreau Biographical Sketch
Victor is the Head of Eden a at Eden Tech, specializing in microfluidic solutions that transform research and manufacturing. He holds three Master’s degrees in Numerical Simulation, Microfluidics, and Complex Physics, equipping him with a strong technical foundation in fluid dynamics, modeling, and advanced fabrication techniques. His expertise spans from microfluidic design to scalable production methods, making him a key advocate for innovative, accessible, and high-performance microfluidic technologies. At Eden Material, he plays a pivotal role in business development, forging strategic partnerships, and expanding the adoption of cutting-edge solutions in the microfluidics community.
Wei Gao, Professor, California Institute of Technology

Wei Gao Biographical Sketch
Wei Gao is a Professor of Medical Engineering and Heritage Medical Research Institute Investigator at the California Institute of Technology. He earned his Ph.D. from the University of California, San Diego in 2014, followed by a postdoctoral fellowship at the University of California, Berkeley from 2014 to 2017. He is an Associate Editor of Science Advances, npj Flexible Electronics, Biosensors and Bioelectronics, and Sensors & Diagnosis. He is a recipient of NSF Career Award, ONR Young Investigator Award, IAMBE Early Career Award, Sloan Research Fellowship, Pittcon Achievement Award, IEEE EMBS Early Career Achievement Award, IEEE EMBS Technical Achievement Award, IEEE Sensor Council Technical Achievement Award, MIT Technology Review 35 Innovators Under 35, and Falling Walls Breakthrough of the Year in Engineering and Technology. He is a World Economic Forum Young Scientist, a Highly Cited Researcher (Web of Science). He is an elected Fellow for AIMBE and RSC. His research interests include wearable biosensors, digital medicine, bioelectronics, flexible electronics, additive manufacturing, and micro/nanorobotics.
Yang Lin, Assistant Professor, University of Rhode Island

Yang Lin Biographical Sketch
Yang Lin is an Assistant Professor of Mechanical Engineering at the University of Rhode Island. He is a recipient of the DARPA Young Faculty Award and the NSF Engineering Research Initiation Award. His work encompasses the sampling, separation, and spectroscopic identification of micro‑ and nanoplastics in environmental and biological samples; acoustofluidic particle manipulation and lab‑on‑chip device development for precision fluid control; and organoid and organ‑on‑chip platforms that enable advanced modeling and sensing for health and environmental studies.
09:00
17 November 2025
Slate Room, VOCO Hotel
Workshop

Stefano Begolo, President, ALine, Inc., United States of America
Antonio “Tony” Pineda, Technical Sales Engineer, ALine, Inc., United States of America
Short Course Focused on:
Microfluidic Product Development: How to Integrate Design for Manufacture from Benchtop to Commercial Scale
**2-hr Course -- All Registered Conference Attendees are Welcome to Attend this Short Course**
This training course is being taught by the ALine team, including Dr Stefano Begoloo, a veteran in the microfluidics, system design and product development space and by Antonio (Tony) Pineda. The goal of this training course is to present an actionable set of tools for translating microfluidic design into products.
Specifically, the following topics will be addressed:
1. Looking at product development from the view point of your stakeholder
2. Create milestones with deliverables that de-risk and build momentum
3. Benchmark your results to assure data integrity; good science is necessary for a viable product
4. When to transition from a working alpha to a beta prototype
5. Understand and balance function and complexity to avoid a high cost of manufacture
The overall goal of this training course is to engage with fellow attendees, engage with the instructor and discuss topics as they relate to your product development efforts.
Subsequent to this course is the 2.5-day main conference and a deep dive into these areas during the conference in presentations and discussions.
**If you are involved in microfluidic product development, this training course is a must-attend**
11:00
17 November 2025
Slate Room, VOCO Hotel
Workshop

Jing Chen, Founder & CEO, HiComp Microtech, United States of America
Short Course Title:
Microfluidics Manufacturing: From Prototyping To Scalable Production
**2-hr Course -- All Registered Conference Attendees are Welcome to Attend this Short Course**
This short course offers a practical introduction to the manufacturing of microfluidic devices, focusing on the transition from lab-scale prototyping to high-volume production.
Topics will include:
1. Key materials used in microfluidics: polymers, silicon, and glass
2. Prototyping techniques such as 3D printing, CNC micromachining, laser cutting, soft lithography (PDMS), and MEMS-based fabrication—along with their capabilities, limitations, and typical applications
3. Challenges in scaling up, including design adaptation, material compatibility, and process scalability
4. Production-ready solutions, including micro-injection molding, various chip bonding strategies, PDMS scale-up methods, and considerations for manufacturing microfluidic MEMS devices as distinct from conventional MEMS used in sensors and actuators
The course will be illustrated with real-world industry case studies, showcasing the latest trends shaping the future of microfluidics in diagnostics, life sciences, and pharmaceutical applications.
13:00
17 November 2025
Conference Venue Entrance
Conference Registration Begins:
Materials Pick-Up
Coffee and Networking in the Exhibit Hall
13:45
17 November 2025
Plenary Ballroom
Conference Welcome and Introduction by Conference Co-Chairpersons:
Professor Dino Di Carlo, Armond and Elena Hairapetian Chair in Engineering and Medicine, Professor and Chair of Bioengineering, University of California-Los Angeles
Dr. Stefano Begolo, President, ALine, Inc.
14:00
17 November 2025
Plenary Ballroom

Martyn Boutelle, Professor of Biomedical Sensors Engineering, Imperial College London, United Kingdom
Real-Time Microfluidic Devices for Healthcare – Premature Baby Monitoring in the NICU
As a person’s physiological regulation of biomarker molecules is challenged by acute illness, exposure to toxins or even surgery, the concentration these molecules can give important information about their health. For premature infants their regulation systems have yet to mature, so they can also suffer rapid changes in biomarker concentrations that can have devastating health consequences for the baby. Our view is that to monitor such biomarker changes effectively ideally requires moment-by-moment measurement of blood or tissue concentrations. The person acts as their own control allowing acute deterioration to be noticed quickly.
We have been developing a range of sensing and biosensing solutions for the invasive, minimally invasive, and non-invasive monitoring of people in healthcare situations. Microfluidics coupled to novel biosensors provide a valuable means of clinical sampling and robust quantification of measured biomarkers.
I will describe the key challenges in the development of such integrated microfluidic sensing devices and present our recent data from the neonatal intensive care unit amongst other projects.
14:30
17 November 2025
Plenary Ballroom

Brian Cunningham, Professor and Intel Alumni Endowed Chair, University of Illinois at Urbana-Champaign, United States of America
Integration of Microfluidic Sample Handling and Detection for Point of Care Diagnostics
Detection of molecular biomarkers in point-of-care settings requires an automated workflow that begins with a clinical sample, processes it with reagents for a selective assay, and delivers an accurate quantitative output in less than 30 minutes, while utilizing low-cost disposable sensors and a portable inexpensive instrument.
This presentation will summarize three recent multidisciplinary and collaborative efforts towards this goal.
First, we will describe the “PathTracker” system (in collaboration with Rashid Bashir, Enrique Valera and Bill King at UIUC), in which a plastic cartridge (produced by either injection molding or additive manufacturing) processes a droplet of whole blood to release the nucleic acid content of viral pathogens that are selectively detected by multiplexed loop-mediated isothermal amplification (LAMP) assays for Zika, Dengue, and Chikungunya virus. The PathTracker cartridge provides precisely metered volumes off all reagents from onboard reservoirs, while pneumatic pressure for mixing is provided by milliliterrotating a knob.
Second, we will describe a “Biosensor Integrated Recovery Device” (BIRD) that pushes milliliter-scale plasma volumes through a series of nanoporous filters to extract and concentrate nano-objects (such as viruses or extracellular vesicles) within a specific size range, followed by exposure of the filtrate to an integrated photonic crystal biosensor.
Finally, we will share recent efforts to develop and demonstrate paper-based lateral flow test strips that utilize ultra bright plasmonic fluor tags that can be detected with a pocket-sized, fluorescence reader. The system has been characterized for high sensitivity detection of gonorrhea antigen in urine.
15:00
17 November 2025
Plenary Ballroom

H. John Crabtree, President and Founder, HJC Consulting Inc., Canada
Negotiating the Challenges of Microfluidic Product Development
What are the areas that must be considered to carry a microfluidic product brainchild from brilliant concept to benchtop model, miniaturised prototype, beta and eventually launched product? There are many, and several should be considered in parallel to give you a fighting chance of making it to product launch on the other side of the gap ... before your funds run out or your competition steals your lunch!
Based on 13+ years of consulting to start-ups and multinationals alike (and occasionally to university tech transfer offices and public tech support agencies) on a variety of product development, IP review and due diligence projects, a survey of these PD scope areas and a general outline of how these projects typically proceed will be provided. Topic areas that will be addressed include product definition, IP landscaping, quality and regulatory standards, product concept and materials considerations, iterative design, prototyping, testing & evaluation, and transfer to manufacturing.
15:30
17 November 2025
Exhibit Hall
Mid-Afternoon Coffee Break and Networking in the Exhibit Hall
16:00
17 November 2025
Plenary Ballroom

Daniel Chiu, A. Bruce Montgomery Professor of Chemistry, University of Washington, United States of America
Digital Flow Cytometry (dFC)
We have developed a multi-parametric high-throughput and high-sensitivity flow-based method for counting single molecules, and applied this method to the analysis of individual extracelluar vesicles and particles (EVPs). EVPs are promising biomarkers but they are highly heterogeneous and comprise a diverse set of surface proteins as well as intra-vesicular cargoes. Yet, current approaches to the study of EVPs lack the necessary sensitivity and precision to fully characterize and understand the make-up and the distribution of various EVP subpopulations that may be present. Digital flow cytometry (dFC) provides single-fluorophore sensitivity and enables multiparameter characterization of EVPs, including single-EVP phenotyping, the absolute quantitation of EVP concentrations, and biomarker copy numbers. dFC has a broad range of applications, from analysis of single EVPs such as exosomes or RNA-binding proteins to characterization of therapeutic lipid nanoparticles, viruses, and proteins. dFC also provides absolute quantitation of non-EVP samples such as dyes, beads, and Ab-dye conjugates.
16:30
17 November 2025
Plenary Ballroom

Holger Schmidt, Narinder Kapany Professor of Electrical Engineering, University of California-Santa Cruz, United States of America
Integrated Electro-optofluidic Devices for Ultra-sensitive Diagnostics and Biomedical Research
Managing seemingly incompatible performance metrics such as sensitivity, size, speed, complexity, and versatility has long been a challenge for biomedical sensors, often resulting in prioritization of some aspects over others depending on the application. I will discuss the integration of optical and electrical single molecule analysis in a lab-on-chip format and their use in a wide variety of practical applications. By integrating optical waveguides and solid-state nanopores in a microfluidic setting, target-agnostic detection with high sensitivity, low complexity, rapid turnaround and wide dynamic range was demonstrated. Examples will include infectious disease diagnostics, liquid biopsies for cancer treatment, continuous exosome analysis in 3D organoid tissue culture platforms, and on-chip spectroscopy as a new avenue for lab-on-chip miniaturization.
17:00
17 November 2025
Plenary Ballroom

Chang-Jin "CJ" Kim, Distinguished Professor, University of California-Los Angeles, United States of America
Democratization of Digital Microfluidics via Cloud-based Design and Manufacturing
Despite a large number of publications, electrowetting-on-dielectric (EWOD) digital microfluidics (DMF) is yet to achieve the once-anticipated wide adoption. To democratize DMF for easy adoption, a group of labs has been developing a cloud-based platform of standardized design and manufacturing. The platform is aimed to empower any user to design, obtain, and operate DMF chips (https://edroplets.org). For chip design, a web-based EWOD chip design platform allows layout rules and automated wire routing. For chip manufacturing, a web-based EWOD chip manufacturing platform facilitates fabrication of four types of EWOD chips (i.e., glass, paper, PCB, and TFT) to suggest the foundry service workflow of the future. For chip control, a compact EWOD control system is available along with web-based operating software. Our goal is to inspire academic and commercial stakeholders to join the initiative toward a DMF ecosystem for the masses.
18:00
17 November 2025
Plenary Ballroom

Gregory Nordin, Professor, Brigham Young University, United States of America
3D-Printed Microfluidics: Principles, Options, and Recent Advances
3D printing enables the direct fabrication of complex, enclosed microfluidic devices, eliminating the need for molds, layer alignment, and post-fabrication bonding that characterize many conventional processes. However, considerable confusion persists regarding the feasibility of 3D printing for the interconnected negative features essential to microfluidics. This often stems from equating manufacturer-reported resolution specifications with actual achievable dimensions, as well as from insufficient understanding of the underlying processes and optimal strategies for their application. This presentation introduces a conceptual framework to clarify what is possible and how to effectively leverage 3D printing for microfluidic device fabrication, including both DLP and LCD resin printers. We also emphasize the expanded capabilities afforded by full user control over the printing process. As illustrative examples, we present results from our custom DLP 3D printers and resins, including channels with 2 μm × 2 μm cross-sections, valves featuring 15 μm × 15 μm active areas, integrated dose-response assay chips, and a single device incorporating 11,200 valves with 100% yield that demonstrates the complexity now becoming feasible with tailored 3D printing processes.
18:30
17 November 2025
Exhibit Hall
Networking Reception and Dinner in Exhibit Hall
**Beer, Wine and Dinner Reception -- Meet Exhibitors and Engage with Colleagues**
20:30
17 November 2025
Close of Day 1 of the Main Conference Programming
20:45
17 November 2025
Slate Room, VOCO Hotel
Workshop

Claudia Gärtner, CEO, microfluidic ChipShop GmbH, Germany
Evening Workshop: Microfluidics for Point-of-Care Diagnostics
Trends
Technologies/Tools
Case Studies
**This Workshop is Open to All Conference Registered Delegates**
22:30
17 November 2025
Close of Day 1 of the Conference
08:00
18 November 2025
Exhibit Hall
Morning Coffee, Tea and Continental Breakfast in the Exhibit Hall
09:00
18 November 2025
Ballroom A

Dino Di Carlo, Armond and Elena Hairapetian Chair in Engineering and Medicine, Professor and Chair of Bioengineering, University of California-Los Angeles, United States of America
Welcome by Conference Senior Chairperson and Introduction to the Emerging Themes in the Broader Lab-on-a-Chip, Microfluidics Space:
**Wearables**
**Digital Microfluidics (DMF)**
09:15
18 November 2025
Ballroom A

Juan G. Santiago, Charles Lee Powell Foundation Professor of Mechanical Engineering, Stanford University, United States of America
Experimental Study of Trapping and Stretching of Single DNA Molecules on a Channel Wall
Trapping, linearization, and imaging of single molecule DNA is of broad interest to biophysicists and has applications to nucleic acid analysis methods such as karyotyping and optical mapping. In this work, we drive DNA molecules with an axial electric field through microchannels and study the dynamics on a single-molecule basis. We discovered a new method to trap and visualize DNA molecules. Namely, above a threshold electric field, individual DNA molecules become pinned to the channel walls at a vertex and fold into a hairpin shape as they are stretched in the direction opposite to the electric field. We hypothesize that polyvinylpyrrolidone (PVP), a neutral polymer added to the buffer to suppress electroosmosis, adsorbs on the channel surfaces and forms a scaffold onto which DNA becomes entangled. Upon removal of the electric field, DNA molecules undergo relaxation within a few seconds to a Brownian coil around the vertex. After 10’s of seconds, DNA is released and free to diffuse and electromigrate. We analyze the conditions needed for trapping, the relaxation dynamics, and the repeatability of vertex pinning. The method enables high quality imaging of single-molecule DNA with high throughput using simple-to-fabricate fluidic structures.
09:45
18 November 2025
Ballroom A

Wei Gao, Professor, California Institute of Technology, United States of America
Body-Interfaced Biosensors
The rise of personalized medicine is reshaping traditional healthcare, enabling predictive analytics and tailored treatment strategies. In this talk, I will discuss our progress in developing wearable, implantable, and ingestible electrochemical biosensors for real-time molecular analysis. These bioelectronic systems autonomously access and sample diverse body fluids—including sweat, interstitial fluid, gastrointestinal fluid, wound exudate, and exhaled breath condensate—enabling continuous monitoring of key biomarkers such as metabolites, nutrients, hormones, proteins, and drugs during various activities. To facilitate scalable, cost-effective manufacturing of these high-performance, nanomaterial-based sensors, we employ laser engraving, inkjet printing, and 3D printing techniques. The clinical utility of our biosensors is being evaluated in human and animal studies, focusing on applications such as stress and mental health assessment, precision nutrition, chronic disease management, and personalized drug monitoring. Additionally, I will highlight our efforts in energy harvesting from both the body and the environment, opening the door to battery-free, wireless biosensing technologies. By integrating electrochemical biosensing with advanced bioelectronics, we aim to revolutionize personalized healthcare, offering new possibilities for diagnostics, continuous monitoring, and therapeutic interventions.
10:15
18 November 2025
Ballroom A

Mais Jebrail, CTO of Microfluidics, INTEGRA Biosciences, United States of America
Digital Microfluidics and Beyond for NGS Sample Prep
Digital microfluidics offers a more integrated and cost-effective approach to next-generation sequencing (NGS) sample preparation by enabling discrete control of liquid droplets at the nL–µL scale. To bring this technology into practical use in real-world laboratories, key technical challenges had to be addressed. This presentation also introduces a next-level platform that builds on the strengths of digital microfluidics while significantly extending its capabilities. Designed for full automation, enhanced robustness, and scalability, the platform integrates essential NGS sample preparation steps into a compact, cost-effective consumable. The result is a practical, high-performance solution that simplifies workflows and supports high-throughput molecular biology applications.
10:45
18 November 2025
Exhibit Hall
Mid-Morning Coffee Break and Networking in the Exhibit Hall
11:30
18 November 2025
Ballroom A
Technology Spotlight Presentation

Victor Morel Cahoreau, Head of Sales, Eden Microfluidics, France
From Idea to Device: Rethinking Microfluidics with Design-Driven Prototyping and Novel Materials
In the rapidly evolving field of microfluidics, the journey from concept to production often presents a fragmented and time-consuming challenge. This talk presents an integrated workflow designed to streamline microfluidic innovation, from digital design to physical device, in record time. We will introduce a fully web-based CAD and simulation tool tailored for microfluidics, enabling users to iterate faster and more accurately. Next, we explore a true 3D mold fabrication solution that bypasses the limitations of traditional lithography. Finally, we present Flexdym, a next-generation polymer that merges the processability of thermoplastics with the flexibility of silicone, enabling rapid prototyping and scalable manufacturing. By combining digital tools, novel materials, and modular fabrication systems, we offer a new paradigm for microfluidic design, validation, and production.
12:00
18 November 2025
Ballroom A
Technology Spotlight Presentation

Jing Chen, Founder & CEO, Hicomp Microtech, United States of America
Scaling Up Microfluidic Innovations from Lab to Fab
Scaling up microfluidic innovations from laboratory prototypes to large-scale manufacturing presents unique technical and operational challenges. This presentation addresses critical considerations for transitioning microfluidic designs from proof-of-concept devices to mass-produced commercial products. Leveraging Hicomp's expertise in microfluidic chip prototyping, fabrication, and process optimization, we will discuss practical strategies for selecting suitable materials, optimizing chip designs for manufacturability, ensuring robust quality control, and streamlining production workflows. Real-world examples and insights will illustrate common pitfalls, effective solutions, and best practices to facilitate successful scale-up. This session aims to provide attendees with actionable guidance on bridging the gap between laboratory innovation and high-volume commercial fabrication.
12:30
18 November 2025
Exhibit Hall
Networking Lunch in Exhibit Hall -- Engage with Colleagues and Network with Exhibitors
15:00
18 November 2025
Ballroom A

Maximilian Pitzek, Deputy Head of Project Management, STRATEC Consumables GmbH, Austria
From Design to Realization: New, Streamlined Prototyping Workflow for the Development of Microfluidic Platforms
In this work we present an integrated development workflow of computational fluid dynamics (CFD) simulation and experimental validation using a new combined prototyping approach that enables both high flexibility with large number of design variants, as well as high manufacturing precision which is needed for accurate experimental conclusions. This is achieved by embedding two-photon polymerization (2PP) 3D-printed junctions within finished injection-molded and bonded chips. The chips are then tested on the FDA-approved, and commercially available Cytovale IntelliSep® early sepsis detection system. We show that the experimental results are very well in concordance to the simulation data. We acknowledge the contribution of University of Edinburgh, NanoVoxel and Cytovale.
15:30
18 November 2025
Exhibit Hall
Mid-Afternoon Coffee Break and Networking in the Exhibit Hall
16:00
18 November 2025
Ballroom A

Yang Lin, Assistant Professor, University of Rhode Island, United States of America
Microfluidic Platforms for Micro- and Nanoplastic Detection and Cellular Response Studies
Micro- and nanoplastics are emerging environmental and biomedical concerns, with growing interest in their detection and health impacts. This talk presents our recent work on lab-on-a-chip platforms for the sampling and characterization of plastics across environmental and biological matrices. I will introduce microfluidic particle-trapping and microfiltration devices integrated with Raman spectroscopy and machine learning for rapid identification of micro- and nanoplastics in water samples, along with an acoustic approach for separating microplastics from diluted blood samples. Finally, I will discuss in vitro studies on the cellular responses to polystyrene particles, emphasizing the effects of environmental weathering and simulated gastric fluid exposure on particle surface properties and cytotoxicity.
16:30
18 November 2025
Ballroom A

Roman Voronov, Associate Professor, Otto H. York Department of Chemical and Materials Engineering, New Jersey Institute of Technology Newark College of Engineering, United States of America
Repurposing Commercial Dental Resins for Low-Cost, 3D-Printed Microfluidic Valves and Pumps
The advancement of automated lab-on-a-chip systems often relies on custom-formulated 3D printing resins, a practice that creates a significant barrier to widespread adoption. To address this, we investigated the "off-label" use of widely available commercial dental resins as a cost-effective alternative for fabricating monolithic microfluidic devices with integrated active components. We explored several valve architectures and, after iterative design optimization, identified geometries that could be reliably fabricated. We then characterized their performance and demonstrated valve utility in a practical application of an on-chip peristaltic pump. The results show comparable performance to custom resins at lower expense and error risk, enabling accessible microfluidics.
17:30
18 November 2025
Ballroom A
Keynote Presentation

Michelle Khine, Professor of Biomedical Engineering, University of California-Irvine, United States of America
Continuous Physiological Monitoring with Soft Electronics
While great advances in medicine has been made in the past century, the overall infrastructure of the healthcare system has not progressed. Patients are still expected to travel to a centralized location for discrete, reactionary based care where the healthcare provider only has a brief window to assess the patient’s health. Unless the symptoms are overt at the time of examination, the subjective evaluation relies heavily on the self-reporting of symptoms from the patient. This often results in delayed or improper diagnoses. In contrast, we know that physiological signals precede clinical deterioration. We have developed a suite of soft, low-cost, unobtrusive, Band-Aid © like physiological sensors to continuously monitor patients’ cardiovascular and pulmonary functions. We seek to continuously quantify subtle physiological changes to predict – and eventually prevent -- the onset of acute clinical events.
18:00
18 November 2025
Ballroom A
Panel Discussion Focusing on Opportunities in Microfluidics -- Chaired by Dr. Stefano Begolo, President, ALine, Inc.
18:30
18 November 2025
Exhibit Hall
Networking Reception and Dinner in Exhibit Hall
**Beer, Wine and Dinner Reception -- Meet Exhibitors and Engage with Colleagues**
20:30
18 November 2025
Close of Day 2 Main Conference Programming
20:30
18 November 2025
Slate Room, VOCO Hotel
Workshop

Victor Morel Cahoreau, Head of Sales, Eden Microfluidics, France
Eden Microfluidics Design to Prototyping of Microfluidics Chips -- On-site Demo
**Design It, Make It, Test It: A Hands-On Microfluidics Prototyping Experience with FLUI'DEVICE and Flexdym**
This Workshop is Open to All Registered Conference Attendees.
Join this interactive workshop to experience a complete microfluidics prototyping workflow, from digital design to a real-world device, in under an hour. Participants will use FLUI'DEVICE, a browser-based platform built for intuitive microfluidic design and simulation. Each design will be brought to life using Flexdym, an alternative to PDMS, and the Sublym hot embossing system, allowing rapid chip prototyping with thermal bonding, no cleanroom required. The session also includes through-hole embossing, showcasing new possibilities in chip functionality and multilayer integration. Whether you're new to microfluidics or looking to accelerate your workflow, this hands-on session is designed to inspire and equip you with practical tools and materials to bridge the gap between design and device.
22:00
18 November 2025
Close of Day 2 of the Conference
08:00
19 November 2025
Exhibit Hall
Morning Coffee, Tea and Continental Breakfast in the Exhibit Hall
09:00
19 November 2025
Ballroom A
Workshop

Steve Soper, Foundation Distinguished Professor, Director, Center of BioModular Multi-Scale System for Precision Medicine, The University of Kansas
Microfluidics and Nanofluidics for In Vitro Diagnostics
In vitro diagnostic tests represent an important application area for microfluidics and even nanofluidics. However, these tests can be complex because of the number of processing steps that must be employed for successfully carrying out each assay, the diverse range of diseases that must be tested each requiring a different workflow, and the diverse set of tests that must be undertaken (screening → diagnostic → prognostic → response to therapy → recurrence). To complicate the process of bringing new tests to the clinical area is the rigorous validation that must be undertaken both analytically and clinically, and the FDA approval process required for all in vitro diagnostic tests.
To address the aforementioned issues microfluidics and even nanofluidics provide an excellent platform for in vitro diagnostic tests and there are examples already in the commercial sector that provide excellent examples, such as Next Generation Sequencing and their flow cell for nucleic acid analyses, and point-of-care tests for infectious disease testing a good example being the RT-qPCR systems for COVD-19.
In this workshop, I will discuss various aspects of the different testing formats for in vitro diagnostics all of which will have a microfluidic thematic focus. Various topical items that will be discussed include:
• Market size and needs for in vitro diagnostic testing
• The do’s and don’ts of bringing new testing platforms to the market (the fall of Theranos)
• Analytical and clinical figures-of-merit for in vitro diagnostic tests
• Requirements for FDA approval
• The use of liquid biopsy markers and microfluidics for in vitro diagnostic testing
• Requirements of microfluidic and even nanofluidic systems for diagnostic testing
• Integrated microfluidic systems for carrying out multi-step assays for diagnostics
• Practical examples:
o Infectious disease testing (COVID-19)
o Point-of-care diagnostic tests for cerebral vascular diseases
o Microfluidics and nanofluidics for the management of cancer-related diseases
10:00
19 November 2025
Ballroom A
Workshop

H. John Crabtree, Board Member, Microfluidics Association
**Workshop Chairperson**
Standardized Approaches to Facilitate the Development and Production of Microfluidic Products
**This workshop chaired by Dr. John Crabtree brings together government and industry participants from the Microfluidics Association to provide guidance and frameworks for the production of microfluidics products
As technologies mature, they are incorporated into product applications, and as applications mature, standards often evolve around them. The development of standards serves the purposes of consumer convenience and user/bystander safety, and they can be driven by industry and supported by governments. Examples in science include oscilloscopes and power supplies that use BNC and banana plug connectors, manual or robotic lab pipettors for sample preparation that adopt the 9-mm spacing standards for 96-well microtiter plates, and fluidic connections that use Luer lock connectors.
The purpose of this workshop is to look at the evolution of standardised approaches in microfluidics products, product development, and research. The increased use of standards in microfluidics is an important step, as it may facilitate widespread acceptance by removing barriers such as incompatible connectors, inconsistent technical terminology, unsuitable materials, and unquantified or uncharacterized figures of merit.
Our workshop speakers will tell us about what their organisations do, and how standardisation in their operations facilitates the development of microfluidic products by drawing from a library of standard microfluidic components or processes. This, in turn, leads to faster and more predictable development stage, which ultimately benefits their customers, and the microfluidic community at large.
**This interactive workshop is open to all registered conference attendees**
12:00
19 November 2025
Exhibit Hall
Networking Lunch in Exhibit Hall -- Engage with Colleagues and Network with Exhibitors
15:00
19 November 2025
Ballroom A

Magdalena Urban, Researcher, University of Strathclyde, United Kingdom
Development of a Modeling Environment and its Application to Blood-Brain Barrier (BBB) Investigation
Neurodegenerative diseases are a growing global health challenge, with current treatments obstructed by difficulties in modeling, diagnosing, and treating complex conditions. This research addresses one of the key obstacles—understanding the blood-brain barrier (BBB)—by developing a novel microfluidic system that mimics the dynamic environment of the BBB. This work focuses on the design of an acoustofluidic device that integrates a surface acoustic wave (SAW) driven micropump to generate pulsatile flow and shear stress within a vascular-like lumen. The micropump is used in conjunction with a closed-loop system to drive fluid through the microfluidic device, which is created to mimic the BBB model. Central to the design is the investigation of an acoustic whispering gallery mode (WGM) that can manipulate cell behavior in the vascular-like wall, with the potential to temporarily disrupt the BBB and enable drug delivery. Computer-aided design (CAD) software and finite element analysis (FEA) simulations were used to optimize the microchannel system, with promising results for both fluid flow generation and WGM frequency tuning. Both devices were fabricated using the stereolithography technique for mold printing employing a combination of two types of resins to create a complex 3D microchannel system. Microfluidics were examined using a CT X-ray scan and subjected to testing. Theoretical and experimental results from the research would be discussed.
15:30
19 November 2025
Ballroom A

Ding Tang, Researcher in Bioengineering, University of Pennsylvania, United States of America
**Professor David Issadore Laboratory**
Ultrasensitive RNA Quantification Using a High-throughput Droplet Digital CRISPR-Cas13a Assay
Early, accurate, and accessible detection of infectious RNA is pivotal for effective communicable disease intervention and public health surveillance. However, current RNA detection methods, such as RT-qPCR, require thermal cycling and bulky centralized infrastructure, limiting their utility in decentralized or resource-limited settings. We present a high-throughput droplet digital CRISPR-Cas13a assay that enables ultrasensitive, isothermal, and rapid quantification of HIV-1 RNA. Leveraging a millipede-based optofluidic platform capable of generating and analyzing ~15 million droplets per minute, this approach integrates single-RNA droplet partitioning with CRISPR-Cas13a-mediated collateral cleavage for fluorescent signal amplification. Digital quantification across droplets enables qPCR-level sensitivity without the need for thermal cycling. We focus on refining the assay’s sensitivity and specificity by optimizing CRISPR RNA design, Cas13a ortholog selection, and reaction conditions to mitigate false-positive activity and maximize signal-to-noise in picoliter-scale droplets. These efforts aim to establish a robust proof of concept for a droplet digital CRISPR-Cas13a platform that can support both clinical RNA screening and real-time infectious disease monitoring. Beyond clinical diagnostics, we envisage broader applications in areas such as outbreak surveillance, wastewater monitoring, and food safety, where point-of-care-compatible and ultrasensitive RNA quantification can enhance frontline response and biosafety infrastructure.